Phibro Animal Health (PAHC) Q1 FY2027 earnings: revenue $387 million, up 6.3% on the year

Phibro Animal Health Corp. (PAHC) reported revenue of $387 million for Q1 FY2027, the quarter ended 30 September 2026, up 6.3% on the same quarter a year earlier. Net income was $30 million, up 11.3% on the year, and diluted earnings per share $0.72. The figures are the company's own, from the 10-Q it filed with the SEC on 4 November 2026.

Revenue

$387 million

+6.3% on the year · -2.5% on the quarter

Q2 FY2025Q1 FY2027

Operating margin

12.8%

14.1% a year earlier

Q2 FY2025Q1 FY2027

Net income

$30 million

+11.3% on the year · +36.0% on the quarter

Q2 FY2025Q1 FY2027

Diluted EPS

$0.72

+10.8% on the year · +38.5% on the quarter

Q2 FY2025Q1 FY2027

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 7 kept.

Net sales rose 6% to $386.8 million: Net sales were $386.8 million against $363.9 million a year earlier. Management said results exceeded its expectations, led largely by Mineral Nutrition and Performance Products.
Adjusted EBITDA rose 4% to $64.3 million: Adjusted EBITDA was $64.3 million against $61.9 million, a total margin of 16.6% against 17.0%.
Fiscal 2027 guidance maintained on cost timing: Management maintained fiscal 2027 guidance, citing the timing of certain costs and assumptions already built into its plan.

Read the earnings call summary

Income statement (profit and loss)

$ million	Q1 FY2027	Q4 FY2026	Q1 FY2026	On the quarter	On the year
Revenue	387	397	364	-2.5%	+6.3%
Cost of revenue	258	262	244	-1.6%	+5.8%
Gross profit	129	134	120	-4.4%	+7.3%
Gross margin	33.2%	33.9%	32.9%
Selling, general and administrative	78.9	86.2	68.5	-8.5%	+15.1%
Operating income	49.6	48.2	51.3	+3.1%	-3.2%
Operating margin	12.8%	12.1%	14.1%
Interest expense	12.3	10.7	12.5	+14.4%	-2.3%
Pre-tax income	38.8	32.3	36.3	+19.9%	+6.9%
Income tax	9.3	10.6	9.7	-12.9%	-5.0%
Effective tax rate	23.9%	32.9%	26.9%
Net income	29.5	21.7	26.5	+36.0%	+11.3%
Net margin	7.6%	5.5%	7.3%
Diluted EPS	$0.72	$0.52	$0.65	+38.5%	+10.8%

$ million except per share.

Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	Q1 FY2027	Q4 FY2026	Q1 FY2026	On the quarter	On the year
Operating cash flow	26.1	24.1	9.3	+8.3%	+180.4%
Capital expenditure	18.8	18.9	13.8	-0.5%	+36.0%
Free cash flow	7.3	5.2	-4.5	+39.7%
Free cash flow margin	1.9%	1.3%	-1.2%
Cash from investing	-5.9	-16.5	-21.0
Cash from financing	-5.6	-1.6	16.3
Depreciation and amortisation	13.6	13.3	12.8	+1.7%	+5.8%
Share-based compensation	0.8	0.4	0.3	+94.7%	+137.2%
Dividends paid	4.9	4.9	4.9	+0.1%	+0.2%
Dividend per share	$0.12	n/a	$0.12		0.0%
Diluted shares, weighted	41m	41m	41m	-0.0%	+0.2%
Shares outstanding at period end	41m	41m	41m	0.0%	+0.2%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ million	Q1 FY2027	Q4 FY2026	Q1 FY2026	On the quarter	On the year
Shareholders' equity	418	385	312	+8.4%	+34.0%
Debt	735	733	743	+0.3%	-1.1%
Operating lease liabilities	44.4	45.4	33.1	-2.3%	+34.0%
Other liabilities	318	338	298	-5.9%	+6.7%
Total liabilities and equity	1,515	1,501	1,386	+0.9%	+9.3%
Fixed assets	373	369	355	+1.0%	+5.1%
Goodwill	60.0	60.0	59.7	-0.0%	+0.5%
Intangible assets	28.3	30.1	35.0	-5.8%	-19.0%
Investments	7.6	20.6	12.5	-63.2%	-39.4%
Cash and equivalents	75.5	61.4	72.8	+23.0%	+3.8%
Receivables	222	239	218	-7.2%	+1.8%
Inventory	567	535	472	+6.0%	+20.2%
Other assets	182	186	161	-2.5%	+12.8%
Total assets	1,515	1,501	1,386	+0.9%	+9.3%

Questions

What was Phibro Animal Health's revenue in Q1 FY2027?

Phibro Animal Health (PAHC) reported revenue of $387 million for Q1 FY2027, the quarter ended 30 September 2026, up 6.3% on the same quarter a year earlier.

How much did Phibro Animal Health earn in Q1 FY2027?

Net income for Q1 FY2027 was $30 million, up 11.3% on the year, and diluted earnings per share $0.72.

When did Phibro Animal Health report Q1 FY2027 results?

Phibro Animal Health filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 4 November 2026.

Quarterly results, the last 20 quarters

	Q2 FY2022	Q3 FY2022	Q4 FY2022 *	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026	Q4 FY2026 *	Q1 FY2027
Revenue	233	240	255	233	245	246	255	231	250	263	273	260	309	348	379	364	374	384	397	387
Cost of revenue	162	168	177	164	167	170	178	164	171	184	186	177	207	243	269	244	241	258	262	258
Gross profit	70.7	71.6	78.4	68.6	77.4	75.5	76.7	67.7	78.6	79.6	87.2	83.5	102	105	110	120	133	126	134	129
Gross margin	30%	30%	31%	30%	32%	31%	30%	29%	31%	30%	32%	32%	33%	30%	29%	33%	35%	33%	34%	33%
SG&A	48.4	52.4	55.5	55.0	61.5	57.0	52.9	68.5	62.9	59.7	68.7	65.8	76.3	71.1	76.3	68.5	82.3	81.0	86.2	78.9
Operating income	22.3	19.2	22.9	13.7	15.8	18.6	23.8	-0.7	15.7	19.9	18.4	17.7	25.5	33.5	33.7	51.3	50.3	44.7	48.2	49.6
Operating margin	10%	8%	9%	6%	6%	8%	9%	-0%	6%	8%	7%	7%	8%	10%	9%	14%	13%	12%	12%	13%
Interest expense	3.1	3.1	3.4	3.7	4.6	4.9	5.4	5.6	5.7	5.6	6.0	8.8	9.8	9.7	9.0	12.5	12.5	10.7	10.7	12.3
Pre-tax income	23.5	26.8	12.4	5.4	12.1	15.1	21.4	-12.0	3.6	12.9	6.4	9.6	4.8	29.7	23.8	36.3	36.4	32.3	32.3	38.8
Tax rate	26%	34%	39%	29%	40%	34%	46%	n/a	64%	35%	88%	27%	34%	30%	28%	27%	25%	26%	33%	24%
Net income	17.5	17.7	7.5	3.9	7.2	10.0	11.5	-8.0	1.3	8.4	0.8	7.0	3.2	20.9	17.2	26.5	27.5	24.0	21.7	29.5
Net margin	8%	7%	3%	2%	3%	4%	5%	-3%	1%	3%	0%	3%	1%	6%	5%	7%	7%	6%	5%	8%
Diluted EPS	$0.43	$0.44	$0.18	$0.10	$0.18	$0.25	$0.28	-$0.20	$0.03	$0.21	$0.02	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.52	$0.72
Operating cash flow	20.1	6.1	1.6	-10.7	-2.5	6.3	20.2	16.2	31.6	11.4	28.4	12.6	3.1	43.2	21.3	9.3	19.4	16.2	24.1	26.1
Capital expenditure	7.7	10.0	11.9	23.2	9.8	7.9	10.9	7.5	11.0	9.7	13.1	9.6	7.8	7.7	13.1	13.8	11.1	15.3	18.9	18.8
Free cash flow	12.4	-3.9	-10.3	-33.9	-12.3	-1.6	9.3	8.7	20.6	1.7	15.4	3.0	-4.7	35.4	8.1	-4.5	8.3	0.9	5.2	7.3
Dividends paid	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9
Shares outstanding	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	41m	41m	41m	41m	41m	41m	41m	41m
Filing	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 4 November 2026: the filing.